Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
CAN/CSA ISO/TS 17665-3-17 is the Canadian adoption of ISO/TS 17665-3:2017, a Technical Specification that provides guidance on the designation of a medical device to a product family and on processing categories for the validation and routine control of moist heat sterilization. This document supplements the requirements of ISO 17665-1 by offering a structured methodology to group devices that share similar sterilization challenges, thereby reducing the number of separate validation runs without compromising sterility assurance.
The scope covers all medical devices that undergo moist heat sterilization (steam sterilization) in healthcare facilities or industrial settings. It addresses both reusable and single-use devices and applies to the entire sterilization cycle—from pre-conditioning through drying. The guidance is intended for sterilization engineers, quality assurance professionals, regulatory affairs specialists, and anyone responsible for designing or auditing sterilization processes.
A product family is a group of medical devices that, because of similar characteristics (geometry, materials, mass, configuration), present a comparable challenge to the sterilization process. The standard outlines criteria that must be considered when forming a family, including:
Processing categories are broader groupings that reflect the fundamental physical principles governing steam penetration and heat transfer. The standard defines three primary categories, though additional subcategories may be created if justified by risk analysis.
| Processing Category | Typical Devices | Key Sterilization Challenge |
|---|---|---|
| Porous / Absorbent loads | Textiles, bandages, filter media, wrapped trays with absorbent paper | Air removal; condensate retention; drying efficiency |
| Hollow devices | Endoscopes, cannulas, tubing, dental handpieces | Air evacuation from lumens; condensate drainage; internal surface temperature |
| Solid / Non-porous devices | Metal instruments, solid plastic parts, trays without absorbent components | Thermal lag of dense materials; surface condensation; bioburden on flat surfaces |
Within each product family, a single “worst case” device is selected to represent the family during validation. The worst case is the device that is most difficult to sterilize based on the criteria above. The standard provides a decision matrix to compare devices across parameters such as lumen diameter, length, mass, and material density. Quantitative thresholds (e.g., lumen inner diameter < 2 mm, aspect ratio > 150) are suggested but not mandatory—the user must justify the chosen limits.
Implementing CAN/CSA ISO/TS 17665-3-17 within a quality management system (ISO 13485, for example) requires several steps:
The standard also recommends periodic review of product families (e.g., every two years or after any change in sterilizer equipment or cycle recipes). This ensures that family assumptions remain valid as new devices are introduced or existing ones modified.
In Canada, compliance with CAN/CSA ISO/TS 17665-3-17 is not mandatory by regulation, but Health Canada expects sterilization processes for licensed medical devices to be validated in accordance with recognized standards. The Technical Specification is considered “state-of-the-art” guidance for grouping devices and is often referenced during Medical Device Establishment Licence (MDEL) inspections and quality system audits.
For organizations seeking certification to ISO 13485 or MDSAP, demonstrating a systematic approach to product family definition (as outlined in this TS) strengthens the sterilization validation package. Auditors typically look for:
Finally, note that while CAN/CSA ISO/TS 17665-3-17 is a Technical Specification (TS), not a full International Standard, it carries significant weight in regulatory submissions. Its adoption by the Standards Council of Canada as a National Standard of Canada (CAN/CSA) reinforces its authority within the Canadian regulatory framework.
For more detailed guidance, refer to the base document ISO 17665-1 and any applicable regional regulations (e.g., EU MDR or U.S. FDA guidance). The TS is intended to be used in conjunction with—not in place of—the normative requirements of ISO 17665-1.
First published 2025. This article reflects the requirements of CAN/CSA ISO/TS 17665-3-17 as of 2026. Always refer to the latest edition of the standard for regulatory compliance.